Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

PAXgene® Blood DNA Tube

K-Number: K231469 · 2023-06-21

ApplicantPreanalytix GmbH
Decision Date2023-06-21
Product CodePJE
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

PAXgene® Blood DNA Tube is the device name listed in this FDA 510(k) record. The listed applicant is Preanalytix GmbH. It received FDA 510(k) clearance on 2023-06-21 under 510(k) number K231469. The device is classified under product code PJE. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the PAXgene® Blood DNA Tube?

PAXgene® Blood DNA Tube is a medical device that received FDA 510(k) clearance on 2023-06-21. The listed applicant is Preanalytix GmbH. The 510(k) number is K231469.

When did PAXgene® Blood DNA Tube receive FDA 510(k) clearance?

PAXgene® Blood DNA Tube received FDA 510(k) clearance on 2023-06-21, under 510(k) number K231469.

Who is the listed applicant for PAXgene® Blood DNA Tube?

The FDA 510(k) record lists Preanalytix GmbH as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for PAXgene® Blood DNA Tube?

The FDA product code for PAXgene® Blood DNA Tube is PJE.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑